Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting JAK (Janus kinase) pathways. Shows potential in developing treatments for autoimmune diseases such as rheumatoid arthritis and psoriasis due to its ability to modulate inflammatory responses. Also explored for anticancer activity, especially in hematological malignancies where JAK-STAT signaling is dysregulated. Its structure supports high selectivity and binding affinity, making it valuable in optimizing drug candidates for improved efficacy and reduced off-target effects.